ABO gene polymorphisms: a molecular bridge linking disease susceptibility to therapeutic outcomes - Scorecard - MDSpire

ABO gene polymorphisms: a molecular bridge linking disease susceptibility to therapeutic outcomes

  • By

  • Shaoqing Yin

  • Jiaye Li

  • Wei Zhang

  • Rui Ding

  • Yan Li

  • Kai Wang

  • Wenjian Jiang

  • Yi-Da Tang

  • Zhengjun Yi

  • Yaohua Zhang

  • Meng Li

  • June 17, 2026

  • 0 min

Share

Clinical Scorecard: Genetic Variations in the ABO Gene: Connecting Disease Risk to Treatment Responses

At a Glance

CategoryDetail
Condition
Key MechanismsPolymorphisms in the ABO gene affect glycosyltransferase function, influencing disease susceptibility and drug response. Ensure this is directly cited.
Target Population
Care Setting

Key Highlights

    Guideline-Based Recommendations

    Diagnosis

      Management

        Monitoring & Follow-up

          Risks

            Patient & Prescribing Data

            Clinical Best Practices

              Related Resources & Content

              Original Source(s)

              ABO gene polymorphisms: a molecular bridge linking disease susceptibility to therapeutic outcomes

              • by Shaoqing Yin, Jiaye Li, Wei Zhang, Rui Ding, Yan Li, Kai Wang, Wenjian Jiang, Yi-Da Tang, Zhengjun Yi, Yaohua Zhang, Meng Li

              • June 17, 2026

              Related Content

              Dana-Farber Research News 06.01.2026

              This twice-monthly newsletter highlights recently published research where Dana-Farber faculty are listed as first or senior authors. The information is pulled from PubMed and this issue notes papers published from May 1 - 15.

              • by

              • June 1, 2026

              • 38 min
              Viable CAR T-cells remain detectable in cerebrospinal fluid in patients with grade ≥3 ICANS despite corticosteroid therapy

              TIFA: a signaling hub linking inflammation, innate immunity, and human disease